After Hours Gainer
SPRC Scisparc Ltd. -4.46+0.18+4.2%
After Hours:5.83+1.37 (+30.7%)
SciSparc: N2OFF Shareholders Approve Merger with SciSparc's Majority Owned Subsidiary MitoCareX, a Drug Discovery Company Targeting Resistant Cancers Including Pancreatic and Non-Small Cell Lung Cancer
Globe NewswireMon, 29-Sep 4:03 PM
After Hours:6.97+2.51 (+56.3%)
After Hours Decliner
SPRC Scisparc Ltd. -6.09+2.26+59.0%
After Hours:5.43-0.66 (-10.8%)
N2OFF Stockholders Approve Merger with Drug Discovery Company Targeting Resistant Cancers Including Pancreatic and Non-Small Cell Lung Cancer
Globe NewswireThu, 25-Sep 4:01 PM
Premarket Decliner
SPRC Scisparc Ltd. -10.06+2.62+35.2%
Premarket:9.73-0.33 (-3.3%)
SciSparc Announces Positive Results for MitoCareX Bio with its Drug Discovery Platform
Globe NewswireMon, 27-Nov 8:41 AM
